Clinical Trial Update: Pharmacokinetics Study of CKD-11101 and NESP After IV Administration in Health Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study evaluating intravenous administration of CKD-11101 and NESP (darbepoetin alfa) in healthy male volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• CKD-11101
• NESP

Snippet

Sponsor: Chong Kun Dang Pharmaceutical | Conditions: Anemia | Phase 1 | Status: COMPLETED